Online Education and Counseling Regarding Gynecological Examination

January 6, 2023 updated by: Belma Toptas Acar, Aydin Adnan Menderes University

The Effect on Women's Attitude and Anxiety Levels Regarding Gynecological Examination of Online Education and Counseling

This research was carried out to determine the effect of online education and counseling on women's attitudes and anxiety levels regarding gynecological examination.

The research is a pre-test-post-test, randomized controlled experimental study.

Study Overview

Status

Completed

Detailed Description

The research is a pre-test-post-test, randomized controlled experimental study. Simple randomization method was used to assign the participants to the groups. The sample consisted of a total of 100 women (experimental group: 50 women and control group: 50 women). The study was carried out with women who applied to Aydın Adnan Menderes University Application and Research Hospital, Gynecology Clinic, Gynecology Outpatient Clinic and met the study criteria.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aydın, Turkey, 09010
        • Aydın Adnan Menderes University Application and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Applying to Aydın Adnan Menderes University Application and Research Hospital, Gynecology Clinic, Gynecology Clinic,
  • Coming to the examination within the first 3 months after the examination,
  • Internet access,
  • Having a Whatsapp or e-mail address,
  • Able to read and write,
  • Able to speak and understand Turkish,
  • Women in the 18-50 age group are included.

Exclusion Criteria:

  • Having a communication (speech, hearing, etc.) disability,
  • Having any psychological illness,
  • Pregnant and postpartum,
  • Diagnosed with cancer,
  • Women who received infertility diagnosis and treatment were excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: EXPERIMENT GROUP
The trainings were held in groups of 4-6 people. The trainings, which were held in three sessions, were held on the days and times that were convenient for the participants. Since the participants were required to attend all sessions, additional session/sessions were held in case of not being able to attend the trainings. Participants in the control and experimental groups were called and the day they would come for the control was determined, and they went to the gynecology outpatient clinic. The post-test questionnaire was applied to the participants in the control and experimental groups in the first 3 months. Until the end of the research, the participants were told that they could reach the researcher at any time and ask questions. Finally, at the 6th month, a post-test form was applied to the participants.
Online education and counseling regarding gynecological examination
No Intervention: CONTROL GROUP
No training or counseling was given to the control group. Participants in the control and experimental groups were called and the day they would come for the control was determined, and they went to the gynecology outpatient clinic. The post-test questionnaire was applied to the participants in the control and experimental groups in the first 3 months. Finally, at the 6th month, a post-test form was applied to the participants.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
A pre-test was applied to 100 women constituting the sample of the study.
Time Frame: up to 9 months.
Before the online training and counseling, a pre-test was applied to a total of 100 participants, 50 of which were in the experimental group and 50 in the control group. In the pre-test question form created by the researcher in the light of the literature, sociodemographic (questions 1-9), obstetrics (questions 10-13), gynecological characteristics (questions 14-23) and attitudes towards gynecological examination (16 questions ).
up to 9 months.
The State and Trait Anxiety Inventory was applied to 100 women constituting the sample of the study.
Time Frame: up to 9 months.
The State and Trait Anxiety Inventory, which was developed by Spielberger (1970) and adapted to Turkish by Öner and Le Compte in 1983, was used. The first 20 questions in the scale measure "state anxiety" and the next 20 questions measure "trait anxiety". A score of 0-19 indicates no anxiety. While 20-39 indicates mild anxiety, 40-59 moderate and 60-79 severe anxiety, 80 points are considered as panic. The minimum value to be taken from the state anxiety scale is "0" and the maximum value is "80". The minimum value to be taken from the trait anxiety scale is "0" and the maximum value is "80". As the score increases, the level of anxiety also increases.
up to 9 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The posttest was applied to 68 people who were pretested within the first 3 months after the pretest was applied.
Time Frame: The pre-test implementation phase was completed in 9 months. This process took a total of 1 year, since the last test was applied to the last participants within the 3rd month.
Online training and counseling about gynecological examination was applied to the experimental group. No counseling or training was given to the control group. Trainings on gynecological examination were carried out in 3 sessions by determining the days and hours that women are suitable for via Google Meet. The trainings were carried out in groups of 4-6 people. The women in the experimental and control groups who will come for the examination were reached in advance and information was obtained about when they would come, and they went to the gynecology outpatient clinic on the day they would come for the check-up. The post-test form was applied to the participants face to face and the form was filled by the participant himself. The post-test form included attitude questions about gynecological examination.
The pre-test implementation phase was completed in 9 months. This process took a total of 1 year, since the last test was applied to the last participants within the 3rd month.
The State and Trait Anxiety Inventory was applied to 68 people who were pretested within the first 3 months after the pretest was applied.
Time Frame: The pre-test implementation phase was completed in 9 months. This process took a total of 1 year, since the last test was applied to the last participants within the 3rd month.
The State and Trait Anxiety Inventory, which was developed by Spielberger (1970) and adapted to Turkish by Öner and Le Compte in 1983, was used. The first 20 questions in the scale measure "state anxiety" and the next 20 questions measure "trait anxiety". A score of 0-19 indicates no anxiety. While 20-39 indicates mild anxiety, 40-59 moderate and 60-79 severe anxiety, 80 points are considered as panic. The minimum value to be taken from the state anxiety scale is "0" and the maximum value is "80". The minimum value to be taken from the trait anxiety scale is "0" and the maximum value is "80". As the score increases, the level of anxiety also increases.
The pre-test implementation phase was completed in 9 months. This process took a total of 1 year, since the last test was applied to the last participants within the 3rd month.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Filling in the second post-test questionnaire online in the 6th month after both groups filled out the pre-test questionnaire.
Time Frame: Since the second posttest form was 3 months after the first posttest form (6 months after the pretest questionnaire), this process was completed in the 15th month from the beginning of the study in total.
Online training and counseling about gynecological examination was applied to the experimental group. No counseling or training was given to the control group. The post-test form was applied to the participants online. The same questions regarding the gynecological examination included in the posttest questionnaire, which must be completed within the first 6 months after the pretest is completed.
Since the second posttest form was 3 months after the first posttest form (6 months after the pretest questionnaire), this process was completed in the 15th month from the beginning of the study in total.
The State and Trait Anxiety Inventory was administered again in the 6th month to 68 people who were posttested in the first 3 months.
Time Frame: Since the second posttest form was 3 months after the first posttest form (6 months after the pretest questionnaire), this process was completed in the 15th month from the beginning of the study in total.
The first 20 questions in the scale measure "state anxiety" and the next 20 questions measure "trait anxiety". A score of 0-19 indicates no anxiety. While 20-39 indicates mild anxiety, 40-59 moderate and 60-79 severe anxiety, 80 points are considered as panic. The minimum value to be taken from the state anxiety scale is "0" and the maximum value is "80". The minimum value to be taken from the trait anxiety scale is "0" and the maximum value is "80". As the score increases, the level of anxiety also increases
Since the second posttest form was 3 months after the first posttest form (6 months after the pretest questionnaire), this process was completed in the 15th month from the beginning of the study in total.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: BELMA TOPTAŞ ACAR, Res.assist, belma.toptas@adu.edu.tr

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 4, 2021

Primary Completion (Actual)

March 7, 2022

Study Completion (Actual)

September 7, 2022

Study Registration Dates

First Submitted

October 2, 2022

First Submitted That Met QC Criteria

January 6, 2023

First Posted (Actual)

January 18, 2023

Study Record Updates

Last Update Posted (Actual)

January 18, 2023

Last Update Submitted That Met QC Criteria

January 6, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • BELMA TOPTAŞ ACAR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

I have completed the data of my doctoral thesis. There were 37 experimental groups and 31 controls who completed the study to the end. I wrote my thesis. After making the necessary arrangements with my advisor, I will have my thesis defense exam in December 2022. I will share the summary of my thesis within the month after the defense.

IPD Sharing Time Frame

January 2023- December 2024

IPD Sharing Access Criteria

Klinik Çalışma Raporu (KSS)

IPD Sharing Supporting Information Type

  • Clinical Study Report (CSR)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gynecological Disease

Clinical Trials on Online education and counseling

3
Subscribe